MedPath

Effect of Tara Mandura Guda in Obesity

Phase 3
Conditions
Health Condition 1: E669- Obesity, unspecified
Registration Number
CTRI/2024/07/071187
Lead Sponsor
Dr Vidya Maishale
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient having classical signs and symptoms of

Sthoulya.

2. Patient with BMI above 25 and below 40.

3. Both fresh and treated cases, who are not on

medication for obesity atleast for 1 month.

4. Subjects willing to sign consent.

Exclusion Criteria

1. Pregnant and Lactating women’s.

2. Diagnosed cases of PCOD, Hypothyroidism,

Diabetes mellitus and Hypertension who are on

medications.

3. Any other conditions where researcher may feel

it may intervein the study.

4. Patients under on going concomitant medications

which may intervein the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of Trial drug on improvement in classical symptoms of Sthoulya (Obesity)Timepoint: 15day, 30day, 60day
Secondary Outcome Measures
NameTimeMethod
Safety of the trial drug and adverse drug reaction and aggravation in the symptoms of Sthoulya (Obesity)Timepoint: 15day, 30day, 60day
© Copyright 2025. All Rights Reserved by MedPath